๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer
NCT03857737Early Gastric Cancer
Peking University Third Hospital
Not applicable
300
Beijing
2019-03-01
Recruiting
Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC
NCT03872661Lung Cancer Stage III
Sun Yat-sen University
Phase 2
36
Guangzhou
2019-03-01
Recruiting
Distribution of Lymph Node Metastases in Esophageal Carcinoma
NCT03222895Esophageal Neoplasms, Lymph Node Metastases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
5,000
Shanghai
2019-03-01
Recruiting
Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma
NCT03785743Pancreatic Carcinoma, Laparoscopic, Pancreaticoduodenectomy
Tongji Hospital
Not applicable
200
Wuhan
2019-03-01
Recruiting
Tissue-engineered Skin Graft Repair of Autologous Scar Dermal Scaffolds
NCT04389164Scar
First Affiliated Hospital, Sun Yat-Sen University
Not applicable
226
Guangzhou
2019-03-01
Recruiting
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
NCT05326295Breast Neoplasms, Neoplastic Cells, Circulating, Chemotherapy Effect
Hunan Cancer Hospital
Observational
1,000
Changsha
2019-03-01
Recruiting
Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia
NCT03703271Gestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University
Phase 3
70
Hangzhou
2019-03-01
Recruiting
A Real World Study of Respiratory Critical Disease.
NCT07165717ARDS (Acute Respiratory Distress Syndrome), Real World Study
Ming Zhong
Observational
500
Shanghai
2019-03-01
Active, closed
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
NCT03836261Chronic Lymphocytic Leukemia
Acerta Pharma BV
Phase 3
984
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang
2019-02-25
Recruiting
Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF
NCT03920618Hepatitis B, Acute-On-Chronic Liver Failure
Third Affiliated Hospital, Sun Yat-Sen University
Not applicable
150
Guangzhou
2019-02-21
Active, closed
Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors
NCT03821935Advanced Solid Tumors Cancer
AbbVie
Phase 1
364
2019-02-21
Recruiting
Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment
NCT03829553Breast Cancer
Ruijin Hospital
Phase 3
801
Shanghai
2019-02-21
Active, closed
Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)
NCT03847857Esophageal Anastomotic Leak
Sun Yat-sen University
Phase 3
360
Guangzhou, Jieyang, Shantou, Zhongshan, Chengdu, Shanghai
2019-02-21
Recruiting
Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM
NCT03835312Diabetes Mellitus, Type 1, Immunologic Deficiency Syndromes
Children's Hospital of Fudan University
Not applicable
50
Shanghai
2019-02-20
Active, closed
Idiopathic Scoliosis Progression and Sleep-disordered Breathing in Children
NCT03858244Scoliosis Idiopathic, Sleep Disordered Breathing, Obstructive Sleep Apnea
Second Affiliated Hospital of Wenzhou Medical University
Observational
405
Wenzhou
2019-02-18
By invitation
Outcome of Resection for Colorectal Cancer
NCT03837782Laparoscopy
Tianjin Medical University Cancer Institute and Hospital
Not applicable
1,300
Tianjin
2019-02-15
Active, closed
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
NCT03673501Gastrointestinal Stromal Tumors
Deciphera Pharmaceuticals, LLC
Phase 3
453
2019-02-08
Recruiting
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
NCT06690957SSTR-related Disease, Tumor, Positron Emission Tomography, Metastasis
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2019-02-01
Recruiting
The Shengjing Lung Cancer Cohort (SJ-LCC) Study on Risk Factors for Disease Development and Progression
NCT07779005Lung Caner
Shengjing Hospital
Observational
1,500
Shenyang
2019-02-01
Recruiting
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
NCT06725693GLP1-R-related Disease, Tumor, Insulinoma, Positron Emission Tomography
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2019-02-01
Recruiting
PD-1 Combined With Pyrotinib for Chemotherapy Failure HER2 Insertion Mutation Advanced NSCLC
NCT04144569HER2 Insertion Mutation Positive Advanced NSCLC
Yongchang Zhang
Phase 2
30
Changsha
2019-01-30
Active, closed
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
NCT03748641Castration-Resistant Prostatic Cancer
Janssen Research & Development, LLC
Phase 3
765
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Nanjing, Ningbo, Shanghai
2019-01-25
Recruiting
Fecal Microbiota Transplantation for Ulcerative Colitis
NCT03804931Ulcerative Colitis, Fecal Microbiota Transplantation
Guangzhou First People's Hospital
Phase 2/3
120
Guangzhou
2019-01-20
Recruiting
Toripalimab๏ผˆJS001๏ผ‰ as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors
NCT03810339Solid Tumor, Advanced Cancer
Sun Yat-sen University
Phase 2
35
Guangzhou, Guiyang, Wuhan, Dalian
2019-01-15
Recruiting
Coexistence of Cerebral and Coronary Atherosclerosis in Acute Ischemic Cerebrovascular Disease Patients Registry
NCT03788512Coexistence of Cerebral and Coronary Atherosclerosis, Acute Ischemic Cerebrovascular Disease
Xuanwu Hospital, Beijing
Observational
500
Beijing
2019-01-12
Active, closed
ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC
NCT04172259Breast Cancer, Neoadjuvant Chemotherapy
Sun Yat-sen University
Phase 2
156
Guangzhou
2019-01-10
Recruiting
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
NCT03087032Type 2 Diabetes Patients, Overweight and Obesity, Hyperglycaemia (Diabetic)
The First Affiliated Hospital of Xiamen University
Phase 4
164
Xiamen
2019-01-10
Recruiting
Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors
NCT07357636Solid Tumor, Immune-Related Adverse Events, Immunotherapy Toxicity
Shantou University Medical College
Observational
940
Fuzhou, Guangzhou, Sanya, Shantou, Zhengzhou
2019-01-10
Active, closed
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
NCT03754790Hemophilia
Genzyme, a Sanofi Company
Phase 3
281
Beijing, Changsha, Chengdu, Guangzhou, Guiyang, Hangzhou, Jinan, Kunming
2019-01-09
Recruiting
Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors
NCT03891706Solid Tumor
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1
30
Guangzhou
2019-01-08
Active, closed
Intensive Diet and Physical Activity on Diabetes
NCT03839667Type2 Diabetes, Life Style
Shanghai Jiao Tong University School of Medicine
Not applicable
326
Shanghai
2019-01-07
Active, closed
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients
NCT03737643Advanced Ovarian Cancer
AstraZeneca
Phase 3
1,407
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dalian, Guangzhou
2019-01-04
Recruiting
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
NCT04263935Lymphoma, Gene Abnormality
Henan Cancer Hospital
Observational
200
Zhengzhou
2019-01-03
Active, closed
Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer
NCT07298538Unresectable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital
Observational
800
Tianjin
2019-01-01
Active, closed
CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer
NCT07074535Esophageal Squamous Cell Cancer (SCC), Recurrent Laryngeal Nerve Palsy, Deep Learning, Postoperative Complication
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Observational
500
Chongqing
2019-01-01
Recruiting
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
NCT06405321Hepatocellular Carcinoma
Guangxi Medical University
Observational
2,000
Nanning
2019-01-01
Recruiting
Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC
NCT06700382Triple Negative Breast Cancer
Shu Wang
Observational
1,166
Beijing
2019-01-01
Recruiting
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
NCT06950697Lung Cancer, Venous Thromboembolism, Arterial Thromboembolism, Immune Checkpoint Inhibitors (ICIs)
Beijing Chao Yang Hospital
Observational
2,400
Zhengzhou, Hohhot, Beijing
2019-01-01
Recruiting
Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer
NCT06693024HER2-positive Breast Cancer
Shu Wang
Observational
2,806
Beijing
2019-01-01
Recruiting
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
NCT05701787NSCLC, NSCLC Stage IV, NSCLC, Recurrent
Shanghai Chest Hospital
Observational
500
Shanghai
2019-01-01
Active, closed
Bidirectional Cohort Study on Improvement of Quality of Life in Patients After Coronary Intervention With Kuanxiong Aerosol
NCT06480097Angina Pectoris, Kuanzhong Aerosol, Quality of Life, Cardiac Function
Nanfang Hospital, Southern Medical University
Observational
150
Guangzhou
2019-01-01
Recruiting
Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients
NCT06722599HER2-positive Breast Cancer
Shu Wang
Observational
171
Beijing
2019-01-01
Recruiting
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
NCT04106830NMO Spectrum Disorder, MRI, Multiple Sclerosis, MOGAD
Beijing Tiantan Hospital
Observational
1,000
Beijing
2019-01-01
Recruiting
SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC
NCT06889649Radiation Therapy, Targeted Therapy, Immunotherapy, Renal Cancer Metastatic
Peking University First Hospital
Phase 2
30
Beijing
2019-01-01
Recruiting
De-escalation of Neoadjuvant Chemotherapy Regimens With Immunotherapy Among TNBC
NCT06692725Triple Negative Breast Cancer
Peking University People's Hospital
Observational
380
Beijing
2019-01-01
Recruiting
Cerebral Venous Thrombosis Cohort Study in China Mainland
NCT03919305Cerebral Venous Sinus Thrombosis, Deep Cerebral Vein Thrombosis, Cortical Vein Thrombosis
Capital Medical University
Observational
3,000
Beijing
2019-01-01
By invitation
A Randomized Controlled Study of Conservative Treatment of Granulomatous Lobular Mastitis Combined With Psychiatric Disorders
NCT05395949Breast Diseases, Mastitis Granulomatous, Psychiatric Disorder
Wuhan University
Not applicable
50
Wuhan
2019-01-01
Recruiting
Stents Post-dilation With DCB or POBA in Femoropopliteal Arteries
NCT03791970Peripheral Artery Disease
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
180
Shanghai
2019-01-01
Recruiting
Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy
NCT06711068HER2-positive Breast Cancer
Shu Wang
Observational
8,077
Beijing
2019-01-01
Recruiting
Multimodality Imaging in the Screening, Diagnosis and Risk StratifictiON of HFpEF
NCT04603404Heart Failure, Diastolic
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
430
Beijing
2019-01-01
Recruiting
A Single-Center, Retrospective, Propensity-Score-Matched Cohort Study Comparing Drug-Coated Balloon Versus Drug-Eluting Stent for Reducing Immediate Post-Procedural Slow-Flow/No-Reflow in Acute ST-Elevation Myocardial Infarction Patients With High Thrombus Burden
NCT07806370ST Elevation Myocardial Infarction (STEMI), Acute Coronary Syndromes (ACS)
Xijing Hospital
Observational
668
Xi'an
2019-01-01
Recruiting
Dolutegravir Plus Lamivudine Simplified Therapy
NCT03884673HIV/AIDS
Guangzhou 8th People's Hospital
Observational
300
Guangzhou
2019-01-01
Recruiting
Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma
NCT03949231Liver Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 3
200
Guanzhou
2019-01-01
Recruiting
Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study
NCT06350370Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
8,000
Beijing
2019-01-01
Recruiting
Researches About Proximal Humerus Fractures
NCT04523415Proximal Humeral Fracture
Hebei Medical University Third Hospital
Observational
800
Shijiazhuang
2019-01-01
Recruiting
Biomarker-based Alzheimer's Disease Cohort Study (BASIC)
NCT07109999Alzheimer Disease
Xuanwu Hospital, Beijing
Observational
2,835
Beijing
2019-01-01
Recruiting
Chinese ET Registry (CETR)
NCT04198246Essential Tremor
Xiangya Hospital of Central South University
Observational
1,000
Changsha
2019-01-01
Recruiting
IT or IA Infusion of PD1/PDL1/CTLA4 Inhibitors Versus IV for Immunotherapy of Head/Neck Cancers (HNC)
NCT03952065Head/Neck Neoplasm
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3
200
Guanzhou
2019-01-01
Recruiting
Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I
NCT03882840Anti-cancer Cell Immunotherapy, T Cell and NK Cell
Second Affiliated Hospital of Guangzhou Medical University
Phase 1/2
60
Guangzhou
2019-01-01
Recruiting
S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC๏ผ‰
NCT03941561Gastric Cancer
Fudan University
Phase 3
1,006
Anqing, Hangzhou, Hefei, Nanchang, Shanghai, Wuhu
2019-01-01
Recruiting
Liver Volume Metrics for Predicting Immunotherapy Prognosis in Unresectable Hepatocellular Carcinoma
NCT07782632Hepatocellular Carcinoma (HCC)
Anhui Provincial Hospital
Observational
467
Hefei
2019-01-01
By invitation
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001Sepsis, Sepsis and Septic Shock, Infection
Second Affiliated Hospital of Wenzhou Medical University
Observational
100
Wenzhou
2019-01-01
Recruiting
Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast Cancer
NCT06722612HER2-positive Breast Cancer
Shu Wang
Observational
2,916
Beijing
2019-01-01
Recruiting
Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy
NCT06693037HER2-positive Breast Cancer
Shu Wang
Observational
2,092
Beijing
2019-01-01
Recruiting
The Research About Acute Compartment Syndrome
NCT04529330Acute Compartment Syndrome
Hebei Medical University Third Hospital
Observational
80
Shijiazhuang
2019-01-01
Recruiting
The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
NCT06323226Sepsis, Children, Only
West China Hospital
Observational
300
Chengdu
2019-01-01
Active, closed
Model Development and Application Based on Renal Pathology Images
NCT07816874Kidney Diseases, Chronic, Glomerular Diseases, Tubulointerstitial Kidney Diseases, IgA Nephropathy (IgAN)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
8,000
Wuhan
2019-01-01
Active, closed
Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)
NCT03722420Chronic Myeloid Leukemia, Chronic Phase
Il-Yang Pharm. Co., Ltd.
Phase 3
238
Beijing
2018-12-28
Active, closed
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
NCT03725059Breast Cancer
Merck Sharp & Dohme LLC
Phase 3
1,240
Heifei, Shanghai, Beijing, Fuzhou Fujian, Guangzhou, Shijiazhuang, Harbin, Zhengzhou
2018-12-27
Active, closed
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
NCT03734029Breast Cancer
Daiichi Sankyo
Phase 3
557
Hefei, Beijing, Fuzhou, Guangzhou, Harbin, Wuhan, Nanjing, Changchun
2018-12-27
Active, closed
IVUS-guided DK Crush Stenting Technique for Patients With Complex Bifurcation Lesions
NCT03770650Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University
Not applicable
556
Nanjing
2018-12-26
Active, closed
TNT to Increase the Clinical Complete Response Rate for Distal LARC
NCT03840239Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III, Chemoradiation
Sun Yat-sen University
Phase 2
98
Guangzhou
2018-12-25
Active, closed
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
NCT03711032High-risk Non-muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC
Phase 3
1,397
Beijing, Chongqing, Xiamen, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan
2018-12-24
Recruiting
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
NCT03785574Hydatidiform Mole, Gestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University
Not applicable
30
Hangzhou
2018-12-24
Recruiting
Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS)
NCT06092736Microvascular Angina
Qilu Hospital of Shandong University
Phase 4
100
Jinan
2018-12-18
Recruiting
Total Mesorectal Excision(TME) With Lateral Lymph Node Dissection Versus TME After Neoadjuvant Chemo-radiotherapy
NCT03587480Rectal Neoplasm Malignant
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
250
Guangzhou
2018-12-17
Active, closed
Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors
NCT03600233Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumor, Gastro-enteropancreatic Neuroendocrine Tumor, Lung Neuroendocrine Neoplasm
TaiRx, Inc.
Phase 2
34
2018-12-15
Active, closed
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
NCT03701334Early Breast Cancer
Novartis Pharmaceuticals
Phase 3
5,101
Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Nanjing, Suzhou, Changchun
2018-12-07
Active, closed
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
NCT03800134Non-Small Cell Lung Cancer
AstraZeneca
Phase 3
825
Beijing, Changsha, Changzhou, Chengdu, Guangzhou, Guiyang, Hangzhou, Hefei
2018-12-06
Active, closed
Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC
NCT03562637Triple Negative Breast Cancer
OBI Pharma, Inc
Phase 3
575
Beijing, Guangzhou, Nanning, Harbin, Wuhan, Changsha, Nanjing, Changchun
2018-12-05
Recruiting
The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer
NCT03747588Pancreatic Carcinoma, Surgery
Peking Union Medical College Hospital
Not applicable
100
Beijing
2018-12-01
Recruiting
The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques
NCT03753555Stroke, Ischemic, Atherosclerosis, Cerebral
General Hospital of Shenyang Military Region
Phase 4
100
Shenyang
2018-12-01
Recruiting
TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors
NCT03778814Nonsmall Cell Lung Cancer, Solid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guanzhou
2018-12-01
By invitation
Oxycodone and Sufentanil for Analgesia in Hip Surgery
NCT03685188Analgesia, Patient-Controlled
West China Hospital
Phase 4
570
Chengdu
2018-12-01
Active, closed
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
NCT03778957Hepatocellular Carcinoma
AstraZeneca
Phase 3
724
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin
2018-11-30
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
507
Fuzhou, Haikou, Zhengzhou, Changsha, Hengyang, Suzhou, Wuxi, Hangzhou
2018-11-28
Active, closed
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients
NCT03706690Carcinoma, Non-Small-Cell Lung
AstraZeneca
Phase 3
407
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2018-11-27
Active, closed
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
NCT03706365Prostate Cancer
Eli Lilly and Company
Phase 2/3
393
Hefei, Wuhu, Lanzhou, Guangzhou, Harbin, Luoyang, Wuhan, Changsha
2018-11-26
Recruiting
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
NCT03671252Rectal Cancer
Sun Yat-sen University
Phase 3
776
Guangzhou
2018-11-16
Recruiting
Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation
NCT03059043Myopia
Wenzhou Medical University
Not applicable
60
Guangzhou, Changsha, Wenzhou, Beijing, Shanghai
2018-11-16
Recruiting
Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
NCT03349762Colorectal Cancer
Xi Shan Wang
Observational
3,060
Shijiazhuang, Harbin, Wuhan, Changsha, Changzhou, Xuzhou, Yangzhou, Anshan
2018-11-02
Recruiting
Exoneuromusculoskeleton for Upper Limb Rehabilitation After Stroke
NCT03752775Upper Limb Rehabilitation
The Hong Kong Polytechnic University
Not applicable
45
Hong Kong
2018-11-01
Recruiting
Translocator Protein PET/CT in Various TSPO-Related Disease
NCT06725719Neuroinflammation, Stroke, Neurodegenerative Diseases
Tianjin Medical University
Observational
200
Hefei, Qingdao, Tianjin
2018-11-01
Recruiting
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
NCT03755739Hepatocarcinoma, Lung Cancer, Melanoma, Renal Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3
200
Guanzhou
2018-11-01
Recruiting
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
NCT03769129Non Small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University
Not applicable
100
Guangzhou
2018-11-01
Recruiting
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
NCT03731442Esophageal Cancer
Chinese Academy of Medical Sciences
Phase 3
300
Beijing
2018-11-01
Active, closed
Early CMR in Acute MI
NCT07602439Acute Myocardial Infarction (AMI)
The Affiliated Hospital of Xuzhou Medical University
Observational
2,000
Xuzhou
2018-10-31
Recruiting
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation
NCT06381271Aortic Valve Regurgitation
Xijing Hospital
Observational
500
Xi'an
2018-10-30
Recruiting
Biomarkers for Prediction of Tumor Response to Radiotherapy
NCT03744819Solid Tumors
Chuangzhen Chen
Observational
100
Shantou
2018-10-29
Recruiting
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
NCT03180320Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure
Guangdong Provincial Hospital of Traditional Chinese Medicine
Not applicable
150
Guangzhou
2018-10-22
Rows per page Showing 18401–18500 of 19052
Previous 183 184 185 186 187 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=185

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.